Antelope Surgical Solutions, Inc. We are dedicated to developing innovative products that will revolutionize the field of disease management. With our state-of-the-art GMP manufacturing facility and robotic high throughput synthesis capability, we have created a groundbreaking multimodality single-agent diagnostic, radiotherapeutic, and fluorescent image-guided surgical small molecule.

Our patented chemical syntheses are the driving force behind our Biotechnology Startup, allowing us to redefine the field of image-guided surgery. Our technology ensures the definitive in vivo identification of tumors and metastases during surgery, overcoming the limitations of current imaging techniques. We are also developing additional imaging agents for future applications.

As we streamline our long-term pipelines in accordance with GMP standards, we are on track to have the first multimodality radioligand therapeutic agent approved by the US Food and Drug Administration. With our dedication to excellence and groundbreaking solutions, Antelope Surgical Solutions is shaping the future of medical biotech. For further inquiries, prospective projects, or recruitment opportunities, please reach out to us.

Visit our website to learn more about our work. © 2020-2023 Antelope Surgical Solutions, Inc